Lung transplant patients may skip some clinic visits with new app
NCT ID NCT05916495
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether remote monitoring using an app and a home lung function device could safely replace some routine hospital check-ups for lung transplant patients. 76 patients were split into two groups: one received standard in-person care, the other used the app and home tests. The goal was to see if remote care could reduce the number of clinic visits without compromising safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remote monitoring via app and home spirometry
- What this could lead to
- If successful, this could allow some lung transplant patients to have fewer hospital visits while still catching complications early.
- What could go wrong
- This was a small, completed study with 76 patients, so results may not apply to everyone. Remote monitoring might miss some problems that in-person checks would catch.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Manchester University NHS Foundation Trust
Manchester, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- New drug may protect kidneys in lung transplant patients
- Blood test may let lung transplant patients ditch antiviral drugs sooner
- Massive lung transplant study seeks 2,600 patients to unlock better care
- Light sensor may predict kidney failure after lung transplant
- Inhaled cyclosporine aims to halt lung transplant rejection